Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Other Non Operating Income of -$72998.0 for Q1 2026, up 47.17% year-over-year from -$49599.5 in Q1 2025, and up 47.17% quarter-over-quarter from -$138188.0 in Q1 2025.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$72998.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 47.17% year-over-year to -$72998.0; the TTM figure through Mar 2026 stood at $118711.0 (up 33.14% YoY), while the FY2025 annual figure was $399695.0, down 34.74% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$72998.0, up from -$138188.0 in the prior quarter.
- The five-year high for Other Non Operating Income was -$72998.0 in Q1 2026, with the low at -$138188.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,271.00 |
| Mar 31, 2026 | -72,998.00 |
| Jun 30, 2025 | 14,991.00 |
| Mar 31, 2025 | -138,188.00 |
| Jun 30, 2021 | 318,160.00 |
| Sep 30, 2013 | 11,737.00 |
| Jun 30, 2013 | -102,545.00 |
| Mar 31, 2013 | -144,705.00 |
| Dec 31, 2012 | 117,466.00 |
| Sep 30, 2012 | 9,771.00 |
| Jun 30, 2012 | 420,890.00 |
| Mar 31, 2012 | -2,250.00 |
| Dec 31, 2011 | -513.00 |
| Sep 30, 2011 | 10,411.00 |
| Jun 30, 2011 | -1,341.00 |
| Mar 31, 2011 | -168.00 |
| Dec 31, 2010 | 244,478.00 |
| Sep 30, 2010 | -2,711.00 |
| Jun 30, 2010 | -40.00 |